| Blocking lncRNA MALAT1/miR-199a/ZHX1 axis inhibits glioblastoma proliferation and progression K Liao, Y Lin, W Gao, Z Xiao, R Medina, P Dmitriev, J Cui, Z Zhuang, ... Molecular Therapy-Nucleic Acids 18, 388-399, 2019 | 91 | 2019 |
| Blocking lncRNA H19-miR-19a-Id2 axis attenuates hypoxia/ischemia induced neuronal injury Z Xiao, Y Qiu, Y Lin, R Medina, S Zhuang, JS Rosenblum, J Cui, Z Li, ... Aging (albany NY) 11 (11), 3585, 2019 | 61 | 2019 |
| Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma J Cui, Q Zhang, Q Song, H Wang, P Dmitriev, MY Sun, X Cao, Y Wang, ... Neuro-oncology 21 (11), 1436-1446, 2019 | 59 | 2019 |
| Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways L Guo, J Cui, H Wang, R Medina, S Zhang, X Zhang, Z Zhuang, Y Lin Molecular Therapy-Oncolytics 20, 119-131, 2021 | 48 | 2021 |
| L2hgdh deficiency accumulates l-2-hydroxyglutarate with progressive leukoencephalopathy and neurodegeneration S Ma, R Sun, B Jiang, J Gao, W Deng, P Liu, R He, J Cui, M Ji, W Yi, ... Molecular and cellular biology, 2017 | 38 | 2017 |
| Inhibition of PP2A with LB-100 enhances efficacy of CAR-T cell therapy against glioblastoma J Cui, H Wang, R Medina, Q Zhang, C Xu, IH Indig, J Zhou, Q Song, ... Cancers 12 (1), 139, 2020 | 32 | 2020 |
| Disruption of Gpr45 causes reduced hypothalamic POMC expression and obesity J Cui, Y Ding, S Chen, X Zhu, Y Wu, M Zhang, Y Zhao, TRR Li, LV Sun, ... The Journal of clinical investigation 126 (9), 3192-3206, 2016 | 28 | 2016 |
| A Transgenic Mouse Model of Pacak–Zhuang Syndrome with An Epas1 Gain-of-Function Mutation H Wang, J Cui, C Yang, JS Rosenblum, Q Zhang, Q Song, Y Pang, ... Cancers 11 (5), 667, 2019 | 27 | 2019 |
| Combination of PARP inhibitor and temozolomide to suppress chordoma progression X Cao, Y Lu, Y Liu, Y Zhou, H Song, W Zhang, D Davis, J Cui, S Hao, ... Journal of Molecular Medicine 97, 1183-1193, 2019 | 26 | 2019 |
| Inhibition of protein phosphatase-2A with LB-100 enhances antitumor immunity against glioblastoma D Maggio, WS Ho, R Breese, S Walbridge, H Wang, J Cui, JD Heiss, ... Journal of Neuro-oncology 148, 231-244, 2020 | 25 | 2020 |
| Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by Isovalerylspiramycin I J Cui, J Zhou, W He, J Ye, T Westlake, R Medina, H Wang, BL Thakur, ... Journal of Experimental & Clinical Cancer Research 41 (1), 126, 2022 | 17 | 2022 |
| Inhibition of protein phosphatase 2A sensitizes mucoepidermoid carcinoma to chemotherapy via the PI3K-AKT pathway in response to insulin stimulus L Liu, H Wang, J Cui, Q Zhang, W Zhang, W Xu, H Lu, S Liu, S Shen, ... Cellular Physiology and Biochemistry 50 (1), 317-331, 2018 | 16 | 2018 |
| Induction of Immune Response against Metastatic Tumors via Vaccination of Mannan‐BAM, TLR Ligands, and Anti‐CD40 Antibody (MBTA) R Medina, H Wang, V Caisová, J Cui, IH Indig, O Uher, J Ye, A Nwankwo, ... Advanced therapeutics 3 (9), 2000044, 2020 | 13 | 2020 |
| TP5, a peptide inhibitor of aberrant and hyperactive CDK5/p25: a novel therapeutic approach against glioblastoma E Tabouret, H Wang, N Amin, J Jung, R Appay, J Cui, Q Song, A Cardone, ... Cancers 12 (7), 1935, 2020 | 12 | 2020 |
| The Vitamin K Epoxide Reductase Vkorc1l1 Promotes Preadipocyte Differentiation in Mice Y Ding, J Cui, Q Wang, S Shen, T Xu, H Tang, M Han, X Wu Obesity 26 (8), 1303-1311, 2018 | 11 | 2018 |
| Early B cell factor 4 modulates FAS-mediated apoptosis and promotes cytotoxic function in human immune cells S Kubo, R Kataria, Y Yao, JQ Gabrielski, L Zheng, TE Markowitz, W Chan, ... Proceedings of the National Academy of Sciences 119 (33), e2208522119, 2022 | 6 | 2022 |
| Vascular changes in the retina and choroid of patients with EPAS1 gain-of-function mutation syndrome PM Dmitriev, H Wang, JS Rosenblum, T Prodanov, J Cui, AS Pappo, ... JAMA ophthalmology 138 (2), 148-155, 2020 | 5 | 2020 |
| GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway AY Park, M Leney-Greene, M Lynberg, JQ Gabrielski, X Xu, B Schwarz, ... Nature immunology 25 (2), 282-293, 2024 | | 2024 |
| Targeting PP2A with LB100 enhances efficacy of CAIX CAR-T cells against GBM J Cui, Q Zhang, Q Song, H Wang, P Dmitriev, M Sun, JS Rosenblum, ... Cancer Research 79 (13_Supplement), 2260-2260, 2019 | | 2019 |
| RDNA-18. TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/p25: A NOVEL THERAPEUTIC APPROACH AGAINST GLIOBLASTOMA E Tabouret, H Wang, N Amin, C Redon, J Jung, J Cui, Q Song, L Liu, ... Neuro-Oncology 20 (Suppl 6), vi225, 2018 | | 2018 |
